Peginterferon alfa-2b and ribavirin for 12 versus 24 weeks in HCV infection [3] (multiple letters)

Brian B. Borg, Jay H. Hoofnagle, Michael J. Henry, Alessandra Mangia, Angelo Andriulli

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)1182-1183
Number of pages2
JournalNew England Journal of Medicine
Issue number11
Publication statusPublished - Sep 15 2005

ASJC Scopus subject areas

  • Medicine(all)

Cite this